In the Heart and Soul Study, individuals in the highest adiponectin quartile had a substantially greater risk of heart failure hospitalization and mortality, despite adiponectin’s well-established metabolic and endothelial benefits [140]. This evidence concerns the gene ADIPOQ and heart failure.